Ghete Tabita, Kock Farina, Pontones Martina, Pfrang David, Westphal Max, Höfener Henning, Metzler Markus
Department of Pediatrics and Adolescent Medicine University Hospital Erlangen Erlangen Germany.
Bavarian Cancer Research Center (BZKF) Erlangen Germany.
Hemasphere. 2024 Dec 3;8(12):e70048. doi: 10.1002/hem3.70048. eCollection 2024 Dec.
Given the high prevalence of artificial intelligence (AI) research in medicine, the development of deep learning (DL) algorithms based on image recognition, such as the analysis of bone marrow aspirate (BMA) smears, is rapidly increasing in the field of hematology and oncology. The models are trained to identify the optimal regions of the BMA smear for differential cell count and subsequently detect and classify a number of cell types, which can ultimately be utilized for diagnostic purposes. Moreover, AI is capable of identifying genetic mutations phenotypically. This pipeline has the potential to offer an accurate and rapid preliminary analysis of the bone marrow in the clinical routine. However, the intrinsic complexity of hematological diseases presents several challenges for the automatic morphological assessment. To ensure general applicability across multiple medical centers and to deliver high accuracy on prospective clinical data, AI models would require highly heterogeneous training datasets. This review presents a systematic analysis of models for cell classification and detection of hematological malignancies published in the last 5 years (2019-2024). It provides insight into the challenges and opportunities of these DL-assisted tasks.
鉴于人工智能(AI)研究在医学领域的高度普及,基于图像识别的深度学习(DL)算法的开发,如骨髓穿刺涂片(BMA)分析,在血液学和肿瘤学领域正迅速增加。这些模型经过训练,以识别BMA涂片用于细胞分类计数的最佳区域,并随后检测和分类多种细胞类型,最终可用于诊断目的。此外,人工智能能够从表型上识别基因突变。该流程有潜力在临床常规中对骨髓进行准确、快速的初步分析。然而,血液学疾病的内在复杂性给自动形态学评估带来了若干挑战。为确保在多个医疗中心的普遍适用性,并在前瞻性临床数据上实现高精度,人工智能模型将需要高度异质的训练数据集。本综述对过去5年(2019 - 2024年)发表的用于血液系统恶性肿瘤细胞分类和检测的模型进行了系统分析。它深入探讨了这些深度学习辅助任务所面临的挑战和机遇。